Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Filipendula ulmaria* extract, derived from the plant commonly known as meadowsweet, is a multicomponent herbal remedy investigated for its anti-inflammatory, antioxidant, and neuroprotective properties. The extract contains bioactive polyphenols, notably flavonoids like miquelianin (quercetin-3-O-glucuronide) and spiraeoside (quercetin-4'-O-glucoside), as well as salicylates. Research indicates its potential in modulating neuroinflammation and proteostasis, which are key drivers in neurodegenerative conditions such as Parkinson's disease. It has demonstrated geroprotective effects and the ability to enhance heat shock resistance in model organisms like *Caenorhabditis elegans*.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on filipendula ulmaria extract.